ScholarIQanswers from OpenAlex & ORCID
Richard G. Moore
ResearcherPublications, citations & collaboration network
Richard G. Moore is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Richard G. Moore have?
ScholarIQindexed works
Richard G. Moore has 342 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Richard G. Moore have?
ScholarIQcitation count
Richard G. Moore has 15,247 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Richard G. Moore?
ScholarIQh-index
Richard G. Moore has an h-index of 55 in OpenAlex.
What is the i10-index of Richard G. Moore?
ScholarIQi10-index
Richard G. Moore has an i10-index of 138 in OpenAlex.
What is the ORCID of Richard G. Moore?
ScholarIQorcid
The ORCID for Richard G. Moore is on the source record.
What is the OpenAlex record for Richard G. Moore?
ScholarIQopenalex
The OpenAlex for Richard G. Moore is on the source record.
What are the most-cited papers on Richard G. Moore?
ScholarIQmost cited works
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
John D. Teasdale, Richard G. Moore, Hazel Hayhurst, Marie Pope, Susan P. Williams, Zindel V. Segal
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
John D. Teasdale, Richard G. Moore, Hazel Hayhurst, Marie Pope, Susan P. Williams, Zindel V. Segal
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore, D. Scott McMeekin, Amy Brown, Paul DiSilvestro, Michael Craig Miller, W. Jeffrey Allard, W Gajewski, Robert J. Kurman, Robert C. Bast, Steven J. Skates
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian